Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C3495917
Disease: Advanced breast cancer
Advanced breast cancer
0.020 Biomarker disease BEFREE This study implied a potential use of Syk methylation as a valuable biomarker to detect high metastatic potential cancerous lesions and the prospect of AZA to join the arsenal of drug candidates to be developed as a new reagent for management of advanced breast cancer. 21347717 2012
CUI: C3495917
Disease: Advanced breast cancer
Advanced breast cancer
0.020 Biomarker disease BEFREE All these results suggested a potential use of SYK methylation as a valuable biomarker to detect early cancerous lesions and support the use of AZA as a new reagent to the management of advanced breast cancer. 15455373 2005